Immunovia Logo

Immunovia

Develops blood tests for early pancreatic cancer detection in high-risk individuals.

IMMNOV | ST

Overview

Corporate Details

ISIN(s):
SE0006091997 (+2 more)
LEI:
549300KHWL6KK1XGUO81
Country:
Sweden
Address:
Scheelevägen 8, 223 63 LUND
Sector:
Human health and social work activities
Industry:
Other human health activities

Description

Immunovia is a diagnostics company dedicated to revolutionizing the early detection of pancreatic cancer to improve patient survival rates. The company's primary product is the PancreaSure™ test, a simple, blood-based assay designed to identify biomarkers associated with pancreatic cancer in its early, more treatable stages (1 and 2). The test is specifically targeted at individuals at high risk for the disease due to family history or genetic mutations, offering a convenient and accurate method for annual surveillance. By focusing on early detection, Immunovia addresses a critical unmet need in oncology, aiming to provide a diagnostic tool that can significantly enhance patient outcomes for one of the deadliest forms of cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Immunovia AB (publ)
Swedish 48.3 KB
2025-11-28 14:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Immunovia AB (publ)
English 47.3 KB
2025-11-26 08:30
Quarterly Report
Swedish 2.5 MB
2025-11-26 08:30
Quarterly Report
English 2.4 MB
2025-11-13 14:01
Major Shareholding Notification
Swedish 10.6 KB
2025-10-29 18:30
Share Issue/Capital Change
Immunovia genomför en riktad nyemission av aktier till garanter i samband med d…
Swedish 70.3 KB
2025-10-29 18:30
Share Issue/Capital Change
Immunovia carries out a directed issue of shares to guarantors in connection wi…
English 72.5 KB
2025-10-23 16:00
Share Issue/Capital Change
Immunovia offentliggör utfallet i företrädesemissionen
Swedish 67.5 KB
2025-10-23 16:00
Share Issue/Capital Change
Immunovia announces outcome of the rights issue
English 68.7 KB
2025-10-22 12:48
Major Shareholding Notification
Swedish 10.6 KB
2025-10-21 10:22
Major Shareholding Notification
Swedish 10.6 KB
2025-10-20 09:55
Major Shareholding Notification
Swedish 10.6 KB
2025-10-16 08:30
Share Issue/Capital Change
Sista dag för handel med teckningsrätter i Immunovias företrädesemission
Swedish 67.7 KB
2025-10-16 08:30
Share Issue/Capital Change
The last day of trading in subscription rights in Immunovia's rights issue
English 69.7 KB
2025-10-03 15:00
Share Issue/Capital Change
Immunovia publishes information document regarding rights issue
English 69.2 KB

Automate Your Workflow. Get a real-time feed of all Immunovia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Immunovia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Immunovia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-01-03 michael Lofman Other Sell 587,532 1,292,570.40 SEK
2023-06-07 Jeffrey Borcherding Other Buy 350,000 61,810.00 USD
2023-04-06 Hans Johansson Other Buy 14,924 99,990.80 SEK
2023-03-28 Martin Moeller Other Other 1,408 9,433.60 SEK
2022-11-15 Philipp Mathieu Other Buy 150,000 297,000.00 SEK
2022-05-24 Jeffrey Borcherding Other Buy 100,000 150,000.00 SEK
2022-02-22 Peter Andersen Other Buy 6,000 186,000.00 SEK
2021-09-02 Martin Moeller Other Buy 1,056 141,292.80 SEK
2021-05-28 Patrik Dahlen Other Buy 6,860 675,984.40 SEK
2021-05-07 Peter Andersen Other Buy 2,730 297,570.00 SEK

Peer Companies

Euromedis Groupe Logo
Manufactures & distributes medical devices and provides home healthcare for facilities & patients.
France
ALEMG
EXACT SCIENCES CORP Logo
Provides advanced cancer screening and diagnostic tests for early detection and treatment guidance.
United States of America
EXAS
EXAGEN INC. Logo
Provides advanced biomarker tests for diagnosing and monitoring chronic autoimmune diseases.
United States of America
XGN
FALCO HOLDINGS Co.,Ltd. Logo
Provides clinical testing, dispensing pharmacies, and healthcare ICT solutions to medical institutions.
Japan
4671
Fulgent Genetics, Inc. Logo
AI-powered genomic testing for cancer, cardio & rare diseases for healthcare providers.
United States of America
FLGT
Fureasu Co.,Ltd. Logo
Provides visiting massage, nursing, and comprehensive in-home healthcare and caregiving services.
Japan
7062
GC Genome Corporation Logo
Offers genomic analysis and genetic testing for oncology, rare diseases, and pre/neonatal health.
South Korea
340450
GeneDx Holdings Corp. Logo
Provides AI-driven genomic insights for diagnosing rare pediatric and complex disorders.
United States of America
WGS
Guardant Health, Inc. Logo
Develops liquid biopsies for cancer detection, monitoring, and personalized treatment guidance.
United States of America
GH
Guardian Pharmacy Services, Inc. Logo
Long-term care pharmacy offering medication management for senior living and nursing facilities.
United States of America
GRDN

Talk to a Data Expert

Have a question? We'll get back to you promptly.